Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 30: 641-643, 1984;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Assmann, G.
Right arrow Articles by Schulte, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Assmann, G.
Right arrow Articles by Schulte, H.

Clinical Chemistry, Vol 30, 641-643, Copyright © 1984 by American Association for Clinical Chemistry

Apolipoprotein E polymorphism and hyperlipidemia

G Assmann, G Schmitz, HJ Menzel and H Schulte

We tested apolipoprotein E phenotypes in 1557 normolipidemic factory workers and 822 hyperlipidemic hospital patients. We distinguished six different apolipoprotein E phenotypes and determined their frequencies in normolipidemia (factory workers), hypertriglyceridemia, hypercholesterolemia, and mixed hyperlipidemia. For the three homozygous phenotypes E3/3, E4/4, and E2/2, the percentage distribution in the normolipidemic group was 62.2%, 2.2%, and 0.9%, respectively; for the three heterozygous phenotypes E4/3, E3/2, and E4/2, we determined frequencies of 19.9%, 11.7%, and 2.9%, respectively. A higher prevalence of E2/2 homozygosity was observed in hypertriglyceridemic persons (2.5%) and persons affected by mixed hyperlipidemia (5.0%). E4/4 homozygosity occurred more often among hypercholesterolemic patients (5.0%) than normolipidemic persons (2.2%). These data suggest that E2/2 homozygosity and E4/4 homozygosity both predispose to hyperlipidemia. Patients affected by mixed hyperlipidemia should be investigated for their apolipoprotein E polymorphism because of the possible linkage of apolipoprotein E2/2 homozygosity, hyperlipidemia, and atherosclerosis.


The following articles in journals at HighWire Press have cited this article:


Home page
 Stat Methods Med ResHome page
K. G Manton, X. Gu, H. Huang, and M. Kovtun
Fuzzy set analyses of genetic determinants of health and disability status
Statistical Methods in Medical Research, October 1, 2004; 13(5): 395 - 408.
[Abstract] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
E. Liberopoulos, G. Miltiadous, M. Hatzivassiliou, N. Ayrton, E. Bairaktari, M. Cariolou, and M. Elisaf
Apolipoprotein E Polymorphism in Northwestern Greece: Frequency and Effect on Lipid Parameters
Ann. Clin. Lab. Sci., July 1, 2004; 34(3): 347 - 354.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
K. von Bergmann, D. Lutjohann, B. Lindenthal, and A. Steinmetz
Efficiency of intestinal cholesterol absorption in humans is not related to apoE phenotype
J. Lipid Res., January 1, 2003; 44(1): 193 - 197.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
J. E. Eichner, S. T. Dunn, G. Perveen, D. M. Thompson, K. E. Stewart, and B. C. Stroehla
Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review
Am. J. Epidemiol., March 15, 2002; 155(6): 487 - 495.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. Baron, S. Fung, A. Aydin, S. Bahring, E. Jeschke, F. C. Luft, and H. Schuster
Oligonucleotide Ligation Assay for Detection of Apolipoprotein E Polymorphisms
Clin. Chem., October 1, 1997; 43(10): 1984 - 1986.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Association for Clinical Chemistry.